Suchergebnisse - "Büttner, Thomas"

PubPharm (7)

1

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations : Differential Effectiveness by Risk Group?

enthalten in: European urology oncology | 2024

von Santoni, M. | Buti, S. | Myint, Z. | +63

2

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma : data from the ARON-2 retrospective study

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Fiala, O. | Buti, S. | Takeshita, H. | +89

3

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

enthalten in: Clinical genitourinary cancer | 2023

von Santoni, M. | Massari, F. | Myint, Z. | +53

4

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Santoni, M. | Myint, Z. | Büttner, T. | +40

5

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2023

von Santoni, M. | Myint, Z. | Büttner, T. | +40

6

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2023

von Santoni, M. | Myint, Z. | Büttner, T. | +40

7

C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Klümper, N. | Sikic, D. | Saal, J. | +25

1
[1]